What is JPMorgan Chase & Co.'s earnings per share (EPS)?

JPMorgan Chase & Co. (JPM) reported diluted earnings per share of $20.02 for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

JPMorgan Chase & Co. Financials

JPM

Trailing 12 months to June 30, 2026

Revenue $199.4B +13.5% YoY

Net Income $65.0B +15.0% YoY

EPS (Diluted) $23.35 +19.8% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

JPMorgan Chase & Co. (JPM) reported $199.4B in revenue over the twelve months to Jun 30, 2026, up 13.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JPM FY2025 2026-05-01

Thin asset returns become sizable shareholder earnings because a very large leveraged balance sheet does most of the work.

Operating cash flow swung from $107.1B in FY2022 to -$147.8B in FY2025 even though net income remained strongly positive. With assets reaching $4.42T and liabilities rising alongside them, that disconnect says reported cash flow is being driven mainly by balance-sheet reshuffling, so this business is better understood through ROA, ROE, and capital growth than through industrial-style cash conversion.

Return on assets was only 1.3% in FY2025, yet return on equity was 15.7%, showing how modest asset-level profitability is amplified once the company operates with a very large liability base. That means even small shifts in asset returns can materially change shareholder-level results without dramatic changes in reported revenue.

Cash and equivalents fell from $624.2B in FY2023 to $343.3B in FY2025 while total assets still climbed, so the balance sheet became less cash-heavy rather than simply bigger. Equity still rose over the same span despite large buybacks and dividends, which indicates earnings were replenishing capital even as the firm returned cash and kept expanding.

Financial Health Signals

Financial Health Score 52/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of JPMorgan Chase & Co.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Growth

Capital

Efficiency

Credit Quality

Stability

Piotroski F-Score Partial

2/6

JPMorgan Chase & Co. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

$2.59used

For every $1 of reported earnings, JPMorgan Chase & Co. used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$182.4B

YoY+2.8%

5Y CAGR+8.7%

10Y CAGR+6.9%

JPMorgan Chase & Co. generated $182.4B in revenue in fiscal year 2025. This represents an increase of 2.8% from the prior year.

Net Income

$57.0B

YoY-2.6%

5Y CAGR+14.4%

10Y CAGR+8.8%

JPMorgan Chase & Co. reported $57.0B in net income in fiscal year 2025. This represents a decrease of 2.6% from the prior year.

EPS (Diluted)

$20.02

YoY+1.4%

5Y CAGR+17.7%

10Y CAGR+12.8%

JPMorgan Chase & Co. earned $20.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 1.4% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

$343.3B

YoY-26.8%

5Y CAGR-8.2%

10Y CAGR-0.5%

JPMorgan Chase & Co. held $343.3B in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

$5.80

YoY+20.8%

5Y CAGR+10.0%

10Y CAGR+12.9%

JPMorgan Chase & Co. paid $5.80 per share in dividends in fiscal year 2025. This represents an increase of 20.8% from the prior year.

Shares Outstanding

2.70B

YoY-3.5%

5Y CAGR-2.4%

10Y CAGR-3.0%

JPMorgan Chase & Co. had 2.70B shares outstanding in fiscal year 2025. This represents a decrease of 3.5% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Margins & Returns

Net Margin

31.2%

YoY-1.7pp

5Y CAGR+7.0pp

10Y CAGR+5.1pp

JPMorgan Chase & Co.'s net profit margin was 31.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.7 percentage points from the prior year.

Return on Equity

15.7%

YoY-1.2pp

5Y CAGR+5.3pp

10Y CAGR+5.9pp

JPMorgan Chase & Co.'s ROE was 15.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$31.6B

YoY+67.8%

5Y CAGR+37.1%

10Y CAGR+18.9%

JPMorgan Chase & Co. spent $31.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 67.8% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

JPM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JPM quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$199.4B	$182.4B+2.8%	$177.6B+12.3%	$158.1B+22.9%	$128.7B+5.8%	$121.6B+1.4%	$120.0B+3.7%	$115.7B+6.4%	$108.8B+8.0%	$100.7B+4.3%	$96.6B+3.2%	$93.5B-1.6%	$95.1B-2.3%	$97.4B+0.3%	$97.0B-0.2%	$97.2B
SG&A Expenses	$57.2B	$54.5B+6.1%	$51.4B+10.5%	$46.5B+11.6%	$41.6B+8.0%	$38.6B+10.2%	$35.0B+2.4%	$34.2B+3.1%	$33.1B+6.1%	$31.2B+3.3%	$30.2B+1.5%	$29.8B-1.4%	$30.2B-2.1%	$30.8B+0.7%	$30.6B+5.3%	$29.0B
Interest Expense	$98.2B	$97.9B-3.4%	$101.3B+24.6%	$81.3B+211.6%	$26.1B+370.0%	$5.6B-44.2%	$10.0B-62.8%	$26.8B+27.3%	$21.0B+51.7%	$13.9B+41.3%	$9.8B+31.6%	$7.5B-5.5%	$7.9B-15.5%	$9.3B-15.3%	$11.0B-18.8%	$13.6B
Income Tax	$18.8B	$15.5B-6.4%	$16.6B+37.7%	$12.1B+42.0%	$8.5B-24.4%	$11.2B+68.0%	$6.7B-20.8%	$8.4B+1.7%	$8.3B-27.7%	$11.5B+16.9%	$9.8B+56.6%	$6.3B-30.1%	$9.0B+1.9%	$8.8B+15.1%	$7.6B-1.8%	$7.8B
Net Income	$65.0B	$57.0B-2.6%	$58.5B+17.9%	$49.6B+31.6%	$37.7B-21.9%	$48.3B+65.8%	$29.1B-20.0%	$36.4B+12.2%	$32.5B+32.9%	$24.4B-1.2%	$24.7B+1.2%	$24.4B+12.4%	$21.7B+21.6%	$17.9B-16.0%	$21.3B+12.2%	$19.0B
EPS (Diluted)	$23.35	$20.02+1.4%	$19.75+21.7%	$16.23+34.2%	$12.09-21.3%	$15.36+73.0%	$8.88-17.2%	$10.72+19.1%	$9.00+42.6%	$6.31+1.9%	$6.19+3.2%	$6.00+13.4%	$5.29+21.9%	$4.34-16.5%	$5.20+16.1%	$4.48

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$57.3B+15.1%	$49.8B+8.8%	$45.8B-1.4%	$46.4B+3.4%	$44.9B-0.9%	$45.3B+5.9%	$42.8B+0.3%	$42.7B
SG&A Expenses	$15.2B-1.2%	$15.3B+16.9%	$13.1B-3.3%	$13.6B-1.1%	$13.7B-2.7%	$14.1B+13.0%	$12.5B-2.7%	$12.8B
Interest Expense	$25.1B+5.4%	$23.8B+0.1%	$23.8B-6.5%	$25.5B+1.8%	$25.0B+6.2%	$23.6B-2.6%	$24.2B-10.3%	$27.0B
Income Tax	$6.4B+59.6%	$4.0B-3.6%	$4.1B-4.9%	$4.3B+31.9%	$3.3B-12.4%	$3.8B+11.7%	$3.4B-17.4%	$4.1B
Net Income	$21.2B+28.3%	$16.5B+27.1%	$13.0B-9.8%	$14.4B-4.0%	$15.0B+2.3%	$14.6B+4.3%	$14.0B+8.8%	$12.9B
EPS (Diluted)	$7.70+29.6%	$5.94+28.0%	$4.64-8.5%	$5.07-3.2%	$5.24+3.4%	$5.07+5.4%	$4.81+10.1%	$4.37

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

JPM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JPM quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$4.4T+10.5%	$4.0T+3.3%	$3.9T+5.7%	$3.7T-2.1%	$3.7T+10.6%	$3.4T+26.0%	$2.7T+2.4%	$2.6T+3.5%	$2.5T+1.7%	$2.5T+5.9%	$2.4T-8.6%	$2.6T+6.5%	$2.4T+2.4%	$2.4T+4.1%	$2.3T
Cash & Equivalents	$343.3B-26.8%	$469.3B-24.8%	$624.2B+10.0%	$567.2B-23.4%	$740.8B+40.4%	$527.6B+100.1%	$263.6B-5.4%	$278.8B-35.4%	$431.3B+10.3%	$391.2B+8.1%	$361.7B	N/A	N/A	N/A	N/A
Goodwill	$52.7B+0.3%	$52.6B-0.1%	$52.6B+1.9%	$51.7B+2.7%	$50.3B+2.2%	$49.2B+3.0%	$47.8B+0.7%	$47.5B-0.1%	$47.5B+0.5%	$47.3B-0.1%	$47.3B-0.7%	$47.6B-0.9%	$48.1B-0.2%	$48.2B0.0%	$48.2B
Total Liabilities	$4.1T+11.1%	$3.7T+3.1%	$3.5T+5.2%	$3.4T-2.2%	$3.4T+11.1%	$3.1T+28.0%	$2.4T+2.5%	$2.4T+3.9%	$2.3T+1.8%	$2.2T+6.3%	$2.1T-10.1%	$2.3T+6.2%	$2.2T+2.3%	$2.2T+3.5%	$2.1T
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$267.9B+7.6%	$249.0B-3.0%	$256.8B
Total Equity	$362.4B+5.1%	$344.8B+5.1%	$327.9B+12.2%	$292.3B-0.6%	$294.1B+5.3%	$279.4B+6.9%	$261.3B+1.9%	$256.5B+0.3%	$255.7B+0.6%	$254.2B+2.7%	$247.6B+6.8%	$231.7B+9.7%	$211.2B+3.5%	$204.1B+11.2%	$183.6B
Retained Earnings	$416.1B+10.6%	$376.2B+13.0%	$332.9B+12.3%	$296.5B+8.9%	$272.3B+14.9%	$237.0B+6.2%	$223.2B+12.1%	$199.2B+12.1%	$177.7B+9.4%	$162.4B+10.9%	$146.4B+12.7%	$130.0B+12.3%	$115.8B+11.1%	$104.2B+18.0%	$88.3B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$5.0T+2.3%	$4.9T+10.7%	$4.4T-3.0%	$4.6T+0.2%	$4.6T+4.5%	$4.4T+8.9%	$4.0T-4.9%	$4.2T
Cash & Equivalents	$309.8B-0.7%	$312.1B-9.1%	$343.3B+13.2%	$303.4B-27.8%	$420.3B-1.3%	$425.9B-9.3%	$469.3B+8.1%	$434.3B
Goodwill	$52.7B0.0%	$52.7B0.0%	$52.7B0.0%	$52.7B-0.1%	$52.7B+0.2%	$52.6B+0.1%	$52.6B-0.3%	$52.7B
Total Liabilities	$4.6T+2.3%	$4.5T+11.7%	$4.1T-3.3%	$4.2T+0.1%	$4.2T+4.7%	$4.0T+9.5%	$3.7T-5.3%	$3.9T
Total Equity	$374.6B+2.9%	$364.0B+0.4%	$362.4B+0.6%	$360.2B+0.9%	$356.9B+1.6%	$351.4B+1.9%	$344.8B-0.3%	$345.8B
Retained Earnings	$445.0B+3.9%	$428.2B+2.9%	$416.1B+2.1%	$407.4B+2.5%	$397.4B+2.8%	$386.6B+2.8%	$376.2B+2.8%	$366.0B

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Long-Term Debt.

JPM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JPM quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$162.5B	-$147.8B-251.8%	-$42.0B-423.8%	$13.0B-87.9%	$107.1B+37.2%	$78.1B+197.7%	-$79.9B-2052.8%	$4.1B-73.8%	$15.6B+244.2%	-$10.8B-149.5%	$21.9B-70.2%	$73.5B+100.8%	$36.6B-66.1%	$108.0B+330.5%	$25.1B-73.9%	$95.9B
Investing Cash Flow	-$185.8B	-$265.6B-62.5%	-$163.4B-341.6%	$67.6B+149.1%	-$137.8B-6.6%	-$129.3B+50.6%	-$261.9B-403.1%	-$52.1B+73.9%	-$199.4B-805.9%	$28.2B+131.7%	-$89.2B-183.4%	$107.0B+164.6%	-$165.6B-10.1%	-$150.5B-25.6%	-$119.8B+29.8%	-$170.8B
Financing Cash Flow	$248.1B	$269.5B+324.8%	$63.4B+348.1%	-$25.6B+79.7%	-$126.3B-145.7%	$276.0B-53.7%	$596.6B+1708.7%	$33.0B-3.4%	$34.2B+133.3%	$14.6B-85.1%	$98.3B+152.4%	-$187.5B-258.6%	$118.2B+317.4%	$28.3B-67.7%	$87.7B-18.6%	$107.7B
Dividends Paid	$17.3B	$16.6B+12.5%	$14.8B+9.8%	$13.5B-0.7%	$13.6B+5.5%	$12.9B+1.3%	$12.7B+2.8%	$12.3B+22.1%	$10.1B+12.4%	$9.0B+6.1%	$8.5B+7.7%	$7.9B+12.6%	$7.0B+15.4%	$6.1B+16.6%	$5.2B+33.4%	$3.9B
Share Buybacks	$31.7B	$31.6B+67.8%	$18.8B+91.7%	$9.8B+210.7%	$3.2B-82.8%	$18.4B+182.5%	$6.5B-72.8%	$24.0B+20.1%	$20.0B+29.7%	$15.4B+69.7%	$9.1B+61.7%	$5.6B	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$25.3B+88.1%	-$211.8B-276.9%	$119.7B+364.8%	-$45.2B-253.0%	$29.5B+111.7%	-$251.8B-270.4%	$147.8B+299.5%	-$74.1B
Investing Cash Flow	$6.4B+102.9%	-$217.8B-564.5%	$46.9B+320.0%	-$21.3B+87.7%	-$173.1B-46.6%	-$118.1B-770.1%	$17.6B+140.6%	-$43.4B
Financing Cash Flow	$18.8B-95.3%	$400.7B+424.3%	-$123.6B-158.6%	-$47.8B-138.9%	$122.8B-61.4%	$318.1B+374.9%	-$115.7B-1176.7%	$10.7B
Dividends Paid	$4.3B-0.7%	$4.4B-1.0%	$4.4B+5.7%	$4.2B-0.6%	$4.2B+10.0%	$3.8B-0.9%	$3.9B+5.6%	$3.7B
Share Buybacks	$6.8B-18.5%	$8.3B+0.7%	$8.3B-0.3%	$8.3B+10.5%	$7.5B-0.3%	$7.5B+75.0%	$4.3B-32.4%	$6.4B

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

JPM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

JPM quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	31.2%-1.7pp	33.0%+1.6pp	31.4%+2.1pp	29.3%-10.4pp	39.7%+15.4pp	24.3%-7.2pp	31.5%+1.6pp	29.8%+5.6pp	24.3%-1.3pp	25.6%-0.5pp	26.1%+3.3pp	22.9%+4.5pp	18.4%-3.6pp	21.9%+2.4pp	19.5%
Return on Equity	15.7%-1.2pp	17.0%+1.8pp	15.1%+2.2pp	12.9%-3.5pp	16.4%+6.0pp	10.4%-3.5pp	13.9%+1.3pp	12.7%+3.1pp	9.6%-0.2pp	9.7%-0.1pp	9.9%+0.5pp	9.4%+0.9pp	8.5%-2.0pp	10.4%+0.1pp	10.3%
Return on Assets	1.3%-0.2pp	1.5%+0.2pp	1.3%+0.3pp	1.0%-0.3pp	1.3%+0.4pp	0.9%-0.5pp	1.4%+0.1pp	1.2%+0.3pp	1.0%0.0pp	1.0%0.0pp	1.0%+0.2pp	0.9%+0.1pp	0.7%-0.2pp	0.9%+0.1pp	0.8%
Debt-to-Equity	11.21+0.6x	10.61-0.2x	10.82-0.7x	11.54-0.2x	11.73+0.6x	11.12+1.8x	9.28+0.1x	9.22+0.3x	8.91+0.1x	8.80+0.3x	8.50-1.6x	10.10+8.8x	1.270.0x	1.22-0.2x	1.40

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Net Margin	36.9%+3.8pp	33.1%+4.8pp	28.3%-2.7pp	31.0%-2.4pp	33.4%+1.1pp	32.3%-0.5pp	32.8%+2.6pp	30.2%
Return on Equity	5.7%+1.1pp	4.5%+1.0pp	3.6%-0.4pp	4.0%-0.2pp	4.2%0.0pp	4.2%+0.1pp	4.1%+0.3pp	3.7%
Return on Assets	0.4%+0.1pp	0.3%+0.1pp	0.3%0.0pp	0.3%0.0pp	0.3%0.0pp	0.3%0.0pp	0.4%0.0pp	0.3%
Debt-to-Equity	12.39-0.1x	12.46+1.3x	11.21-0.5x	11.66-0.1x	11.75+0.4x	11.40+0.8x	10.61-0.6x	11.17

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Bank of America Corp BAC

$427.7B

Wells Fargo Co WFC

$256.9B

HSBC Holdings plc HSBC

$352.5B

Royal Bk Can RY

$283.2B

Citigroup Inc C

$223.5B

Where JPMorgan Chase & Co. Ranks

Frequently Asked Questions

What is JPMorgan Chase & Co.'s annual revenue?

JPMorgan Chase & Co. (JPM) reported $182.4B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JPMorgan Chase & Co.'s revenue growing?

JPMorgan Chase & Co. (JPM) revenue grew by 2.8% year-over-year, from $177.6B to $182.4B in fiscal year 2025.

Is JPMorgan Chase & Co. profitable?

Yes, JPMorgan Chase & Co. (JPM) reported a net income of $57.0B in fiscal year 2025, with a net profit margin of 31.2%.

What is JPMorgan Chase & Co.'s net profit margin?

JPMorgan Chase & Co. (JPM) had a net profit margin of 31.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does JPMorgan Chase & Co. pay dividends?

Yes, JPMorgan Chase & Co. (JPM) paid $5.80 per share in dividends during fiscal year 2025.

What is JPMorgan Chase & Co.'s return on equity (ROE)?

JPMorgan Chase & Co. (JPM) has a return on equity of 15.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is JPMorgan Chase & Co.'s operating cash flow?

JPMorgan Chase & Co. (JPM) recorded an outflow of $147.8B in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are JPMorgan Chase & Co.'s total assets?

JPMorgan Chase & Co. (JPM) had $4.4T in total assets as of fiscal year 2025, including both current and long-term assets.

Does JPMorgan Chase & Co. buy back shares?

Yes, JPMorgan Chase & Co. (JPM) spent $31.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does JPMorgan Chase & Co. have outstanding?

JPMorgan Chase & Co. (JPM) had 2.70B shares outstanding as of fiscal year 2025.

What is JPMorgan Chase & Co.'s debt-to-equity ratio?

JPMorgan Chase & Co. (JPM) had a debt-to-equity ratio of 11.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JPMorgan Chase & Co.'s return on assets (ROA)?

JPMorgan Chase & Co. (JPM) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is JPMorgan Chase & Co.'s Piotroski F-Score?

JPMorgan Chase & Co. (JPM) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JPMorgan Chase & Co.'s earnings high quality?

For every $1 of reported earnings, JPMorgan Chase & Co. (JPM) used $2.59 of operating cash (-$147.8B OCF vs $57.0B net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is JPMorgan Chase & Co.?

JPMorgan Chase & Co. (JPM) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.